Monogenetic Disorders Testing Market
Monogenetic Disorders Testing Market Scope:
Industry Analysis, Market Size, Growth, Trends Till
Request Sample Report
Monogenetic Disorders Testing Market Size and Growth
The Monogenetic Disorders Testing market is experiencing robust growth due to increasing genetic disorder prevalence and advancements in diagnostic technologies. The market size is projected to reach approximately $XX billion by 2026, driven by rising awareness of genetic testing and expanding healthcare providers' adoption of personalized medicine strategies.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Celera Group
◍ Abbott
◍ Thermo Fisher Scientific
◍ ELITech Group
◍ Quest
◍ AutoGenomics
◍ PerkinElmer
◍ Roche
◍ Bio-Rad
◍ Transgenomic
The Monogenetic Disorders Testing Market features key players like Celera Group, Abbott, and Thermo Fisher Scientific. These companies enhance market growth through innovative testing solutions, strategic collaborations, and expansions in diagnostic capabilities. For example, in 2022, Abbott generated approximately $43 billion in revenue, while Thermo Fisher reported around $39 billion.
Market Segmentation
By Application
◍ Hospitals
◍ Specialized Clinics
◍ Ambulatory Surgical Centers
By Product
◍ Carrier Testing
◍ Diagnostic Testing
◍ New-Born Screening
◍ Predictive & Pre-Symptomatic Testing ◍ Prenatal Testing
◍ Others
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
